• Sign In
  • Help
  • My Basket0
Ketamine for Treatment-Resistant Depression: The First Decade of Progress (Hardback)
  • Ketamine for Treatment-Resistant Depression: The First Decade of Progress (Hardback)
zoom

Ketamine for Treatment-Resistant Depression: The First Decade of Progress (Hardback)

(editor), (editor)
£72.00
Hardback 155 Pages / Published: 15/12/2016
  • We can order this

Usually despatched within 3 weeks

  • This item has been added to your basket

Check Marketplace availability

This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation "ketamine-like" fast-acting antidepressants.

Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant has reinvigorated CNS drug discovery research and catalyzed investigation in patient populations historically ignored in antidepressant drug development programs, particularly treatment-resistant patients and those with suicidality. Recent industry and academic research efforts have coalesced to explore NMDA receptor and glutamatergic molecular targets that lack ketamine's psychotomimetic side effects and abuse liability but retain its rapid onset of efficacy. However, many fundamental questions remain regarding the neurobiological mechanisms underlying ketamine's rapid antidepressant effects and the puzzling persistence of benefits observed in some patients following a single dose.

This book examines how insights from these studies are forging new conceptual models of the neurobiology of stress-related affective, anxiety, and addictive disorders and the nature of treatment resistance. It also discusses how ketamine's rapid antidepressant effects provide a scientific platform to facilitate innovation in clinical trial designs pertaining to patient selection, choice of control group, outcome measures, and dose-optimization. This book brings together data and insights from this rapidly expanding and extraordinarily promising field of study. Readers will be able to extract integrated themes and useful insights from the material contained in these diverse chapters and appreciate the paradigm-shifting contributions of ketamine to modern psychiatry and clinical neuroscience research.

Publisher: Springer International Publishing AG
ISBN: 9783319429236
Number of pages: 155
Weight: 428 g
Dimensions: 235 x 155 x 15 mm
Edition: 1st ed. 2016

You may also be interested in...

The Drug Book
Added to basket
£25.00
Hardback
Aromatherapy
Added to basket
£1.99
Paperback
Rang & Dale's Pharmacology
Added to basket
The Dmso Handbook for Doctors
Added to basket
MCQs in Pharmaceutical Calculations
Added to basket
Psychiatric Drugs Explained
Added to basket
The Top 100 Drugs
Added to basket
The Myth of the Chemical Cure
Added to basket
Case Files Pharmacology, 3/e (Int'l Ed)
Added to basket
Pass the PSA
Added to basket
£32.99
Paperback

Reviews

Please sign in to write a review

Your review has been submitted successfully.